These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8345036)
1. Thyrotoxicosis and the heart: something old and something new. Ladénson PW J Clin Endocrinol Metab; 1993 Aug; 77(2):332-3. PubMed ID: 8345036 [No Abstract] [Full Text] [Related]
2. Thyrotoxicosis and the heart--a review of the literature. Kolawole BA; Balogun MO Niger J Med; 2001; 10(2):50-4. PubMed ID: 11705057 [TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone and adrenergic signaling in the heart. Kim B; Carvalho-Bianco SD; Larsen PR Arq Bras Endocrinol Metabol; 2004 Feb; 48(1):171-5. PubMed ID: 15611830 [TBL] [Abstract][Full Text] [Related]
5. [Cardiometric data as indications to surgical treatment of elderly and senile patients suffering from thyrotoxicosis]. Romanchishen AF; Kuz'michev AS; Klimshin SB Vestn Khir Im I I Grek; 2011; 170(4):55-7. PubMed ID: 22191259 [TBL] [Abstract][Full Text] [Related]
6. Thyrotoxicosis and the heart. Woeber KA N Engl J Med; 1992 Jul; 327(2):94-8. PubMed ID: 1603141 [TBL] [Abstract][Full Text] [Related]
7. Cardiac effect of thyrotoxicosis in acromegaly. Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177 [TBL] [Abstract][Full Text] [Related]
8. [Impact of arterial hypertension on the heart]. Herpin D Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398 [TBL] [Abstract][Full Text] [Related]
9. Cardiac abnormalities in myotonic dystrophy type 1. Finsterer J; Stöllberger C Am Heart J; 2004 Dec; 148(6):e33; author reply e34. PubMed ID: 15632870 [No Abstract] [Full Text] [Related]
11. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor. Messerli FH; Ketelhut R J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540 [TBL] [Abstract][Full Text] [Related]
12. Cardiac manifestations and their management in Becker's muscular dystrophy. Orlov YS; Brodsky MA; Allen BJ; Ott RA; Orlov MV; Jay CA Am Heart J; 1994 Jul; 128(1):193-6. PubMed ID: 8017277 [No Abstract] [Full Text] [Related]
13. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone]. Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and treatment of disorders of the heart rhythm in thyrotoxicosis (a review of the literature)]. Litvinenko AF; Lisianskaia SM Vrach Delo; 1989 Jan; (1):22-7. PubMed ID: 2470197 [No Abstract] [Full Text] [Related]
16. Prognostic significance of ventricular arrhythmias in the presence of pathological left ventricular hypertrophy. Ormaetxe JM; Martínez Alday JD; Almendral J; Alfageme Beobide M; Iriarte M Eur Heart J; 1993 Nov; 14 Suppl J():73-5. PubMed ID: 8281968 [TBL] [Abstract][Full Text] [Related]
17. [A typical course of thyrotoxicosis]. Ovcharenko OD Voen Med Zh; 1987 Jan; (1):59. PubMed ID: 3824955 [No Abstract] [Full Text] [Related]
18. [Reversible thyrotoxic cardiopathy secondary to thyrotoxicosis factitia]. Argelich R; Nogué-Xarau S; García-Segarra G; Fernández-Monrás F Med Clin (Barc); 2010 Apr; 134(9):418-9. PubMed ID: 19427002 [No Abstract] [Full Text] [Related]
19. Thyrotoxicosis and the cardiovascular system. Roffi M; Cattaneo F; Brandle M Minerva Endocrinol; 2005 Jun; 30(2):47-58. PubMed ID: 15988401 [TBL] [Abstract][Full Text] [Related]
20. Cardiac disturbances in thyrotoxicosis: diagnosis, incidence, clinical features and management. Vlase H; Lungu G; Vlase L Endocrinologie; 1991; 29(3-4):155-60. PubMed ID: 1821073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]